PRESENTED BY:

V SOWMYA - 181270
K SAIKIRAN - 181242
INCEPTION AND FOUNDERS

• Dr. Reddy's Laboratories is an Indian multinational pharmaceutical

company based in Hyderabad, Telangana, India.
• The company was founded by Anji Reddy in 1984.
• Dr. Reddy's manufactures and markets a wide range of
pharmaceuticals in India and overseas.
• The company has over 190 medications, 60 active pharmaceutical
ingredients (APIs) for drug manufacture, diagnostic kits, critical
care, and biotechnology products.
GROWTH OVER YEARS

• In 1986, Reddy's started operations on branded formulations.

• In 1987, Reddy's started to transform itself from a supplier of
pharmaceutical ingredients to other manufacturers into a
manufacturer of pharmaceutical products.
• In 1992, Reddy’s took first international move to Russia.
• In 1994, Reddy's started targeting the US generic market by building
state of art manufacturing facility.
PRODUCTS AND SERVICES

• GENERICS - Bringing expensive medicines within reach.

• OVER THE COUNTER - Improving access to everyday medicines.
• BIOLOGICS - Large molecule protein therapies for an effective
treatment that may have fewer side effects.
• DIFFERENTIATED FORMULATIONS - Addressing unmet patient
needs.
• CUSTOM PHARMA SERVICES - CPS support pharmaceutical
companies across the value chain from development to
manufacturing and from intermediates and drug substances to drug
products.
SWOT ANALYSIS
STRENGTHS :
• Strong distribution
• Successful track record of developing new products
• High level of customer satisfaction
• Good Returns on Capital Expenditure

WEAKNESS :
• Limited success outside core business
• High attrition rate in work force
• Not highly successful at integrating firms with different work culture
• Days inventory is high compare to the competitors
OPPURTUNITIES :
• Opening up of new markets because of government agreement
• Lower inflation rate
• New environmental policies
• New customers from online channel

THREATS :
• Rising raw material can pose a threat to the Dr. Reddy's Laboratories
Limited profitability.
• The company can face lawsuits in various markets given - different laws
and continuous fluctuations regarding product standards in those
markets.
• The company can face lawsuits in various markets regarding product
standards.
COMPETITORS

• Glenmark is Dr Reddy’s one of biggest rivals, Glenmark has 10,024

fewer employees.
• Zydus Cadila is a top competitor of Dr.Reddy’s, Compared to
Dr.Reddy's, Zydus Cadila has 11,297 fewer employees.
• Intas Pharmaceuticals is perceived as Dr.Reddy's biggest rivals, they
have highest rating compared to Dr.Reddy’s.
INDUSTRY TRENDS AND FUTURE SCOPE

• Prioritize and implement actions to reduce greenhouse gas

emissions.
• Complete Rain Water Harvesting projects and provide Wastewater
recycling facility.
• Making upcoming Special Economic Zones world class and
sustainable by incorporating learnings and industry best practices
in terms of automation, water conservation, GHG emissions
reduction and green products & processes.